Search Results - "Escalera, Begonya Nafria"

Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children by Cheng, Katharine, Mahler, Fenna, Lutsar, Irja, Nafria Escalera, Begonya, Breitenstein, Stefanie, Vassal, Gilles, Claverol, Joana, Noel Palacio, Nuria, Portman, Ron, Pope, Gavin, Bakker, Martijn, Geest, Tessa, Turner, Mark A., Wildt, Saskia N., Lanzerath, Dirk, Tuleu, Catherine, Schwab, Matthias, Smits, Anne, Treluyer, Jean‐Marc, Moretti, Francesco, Wong, Ian, Roes, Kit, Moreno, Carmen, Allegaert, Karel, Helbing, Wim, Naumburg, Estelle, Hoog, Matthijs, Metsvaht, Tuuli, Danne, Thomas, Scarpa, Maurizio, Ruperto, Nicola, Zaoutis, Theoklis, Grigg, Jonathan, Croft, Nick, Schaeffer, Franz, Zuddas, Alessandro, Straub, Volker, Bont, Louis, Cross, Helen

“…Many medicines are used “off‐label” in children outside the terms of the license. Feasible pediatric clinical trials are a challenge to design. Conect4children…”
Get full text

11 Clinical, methodological and patient/parent expert advice in paediatric drug development via conect4children by Mahler, Fenna, Cheng, Katharine, Lutsar, Irja, Nafria Escalera, Begonya, Turner, Mark, de Wildt, Saskia

“…IntroductionChildren have the right to new and improved medicines.conect4children (c4c) aims to promote innovative trial design to optimise paediatric…”
Get full text

Involving children and young people in clinical research through the forum of a European Young Persons’ Advisory Group: needs and challenges by Gaillard, Segolene, Malik, Salma, Preston, Jenny, Escalera, Begonya Nafria, Dicks, Pamela, Touil, Nathalie, Mardirossian, Sandrine, Claverol‐Torres, Joana, Kassaï, Behrouz

“…Children and young people are seen as fundamental to the design and delivery of clinical research as active and reflective participants. In Europe, involvement…”
Get full text

Young patients’ involvement in a composite endpoint method development on acceptability for paediatric oral dosage forms by Reidemeister, Sibylle, Nafria Escalera, Begonya, Marín, Daniel, Balayla, Jan, Klingmann, Ingrid, Klingmann, Viviane

“…Abstract Background In line with the European Paediatric Regulation, the European Medicines Agency (EMA) asks for investigation of a medicine’s acceptability…”
Get full text

The Role of Patients in Health Education by Leggeri, Ilaria, Tarrus Barberillo, Marina, Dutarte, Maria, Nafria Escalera, Begonya, Murphy, Esther, Scalabrini, Silvia, Ariza-Vega, Patrocinio, Carrera, Celine

Get full text

Global Collaborative Social Network (Share4Rare) to Promote Citizen Science in Rare Disease Research: Platform Development Study by Radu, Roxana, Hernández-Ortega, Sara, Borrega, Oriol, Palmeri, Avril, Athanasiou, Dimitrios, Brooke, Nicholas, Chapí, Inma, Le Corvec, Anaïs, Guglieri, Michela, Perera-Lluna, Alexandre, Garrido-Aguirre, Jon, Ryll, Bettina, Nafria Escalera, Begonya

“…Rare disease communities are spread around the globe and segmented by their condition. Little research has been performed on the majority of rare diseases…”
Get full text

Young people advocates on clinical research: educational resources survey by Escalera, Begonya Nafria, Gwara, Meghan E., Thompson, Charles A., Chew, Siaw Yee, Basso, Katryn, Godard, Grant

Get full text

Rare Commons: An Innovative Social Media Platform 2.0 for Collaborative Clinical Research on Pediatric Rare Diseases by Escalera, Begonya Nafria, Gimaré, Mercedes Serrano, López, Jordi Antón, Iglesias, Estibaliz, Torrent, Rosa Bou, Bartomeu, Joan Prat, Mora, Jaume Catala

Get full text

Embedding patient engagement in the R&D process of a life sciences company through co-creation with a patient expert R&D board: a case study by Jobson, Estelle, Garcia, Marta, Sharek, Danika, Risueéo, Laura, Arnould, Sylvain, Lemoine-André, Aude, Geissler, Jan, Amariutei, Ana, Grigolo, Sabrina, Nafria Escalera, Begonya, Smith, Thomas, Sousa, Oriana, Stone, Linda, West, Janet

“…Patient involvement is crucial in healthcare, a factor increasingly recognised by life sciences companies and research institutes. This article presents a case…”
Get full text

Embedding patient engagement in the R D process of a life sciences company through co-creation with a patient expert R D board: a case study by Estelle Jobson, Marta Garcia, Danika Sharek, Laura Risueño, Sylvain Arnould, Aude Lemoine-André, Jan Geissler, Ana Amariutei, Sabrina Grigolo, Begonya Nafria Escalera, Thomas Smith, Oriana Sousa, Linda Stone, Janet West

“…Abstract Patient involvement is crucial in healthcare, a factor increasingly recognised by life sciences companies and research institutes. This article…”
Get full text

Psychopharmacology in children and adolescents: unmet needs and opportunities by Cortese, Samuele, Purper-Ouakil, Diane, Apter, Alan, Arango, Celso, Baeza, Inmaculada, Banaschewski, Tobias, Buitelaar, Jan, Castro-Fornieles, Josefina, Coghill, David, Cohen, David, Correll, Christoph U, Grünblatt, Edna, Hoekstra, Pieter J, James, Anthony, Jeppesen, Pia, Nagy, Péter, Pagsberg, Anne Katrine, Parellada, Mara, Persico, Antonio M, Roessner, Veit, Santosh, Paramala, Simonoff, Emily, Stevanovic, Dejan, Stringaris, Argyris, Vitiello, Benedetto, Walitza, Susanne, Weizman, Abraham, Wong, Ian C K, Zalsman, Gil, Zuddas, Alessandro, Carucci, Sara, Butlen-Ducuing, Florence, Tome, Maria, Bea, Myriam, Getin, Christine, Hovén, Nina, Konradsson-Geuken, Asa, Lamirell, Daphne, Olisa, Nigel, Nafria Escalera, Begonya, Moreno, Carmen

“…Psychopharmacological treatment is an important component of the multimodal intervention approach to treating mental health conditions in children and…”
Get full text

Meeting on data sharing for Duchenne 21–22 March 2019 Amsterdam, the Netherlands by Verhaart, Ingrid E.C., ‘t Hoen, Peter A.C., Roos, Marco, Vroom, Elizabeth

“…•A workshop has been held on data sharing in Duchenne muscular dystrophy.•Currently data is scattered, hard to find and access, causing a huge loss of…”
Get full text